NASHVILLE, Tenn. (WZTV)— A monoclonal antibody “cocktail” discovered by researchers at Vanderbilt University Medical Center reduced the risk of COVID-19 symptoms among chronically ill and immunocompromised adults later exposed to the virus by more than 75 percent, AstraZeneca announced Friday...